Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

Active Trials Industry lead sponsorIndustry collaboratorPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Ovarian Cancer

NCT02090127: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient

No Longer Available

N/A

ficlatuzumab, AV-299, SCH 900105

AVEO Pharmaceuticals, Inc.

Mullerian Mixed Tumor of Ovary

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites